<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                       0001048477
<NAME>                     BioMarin Pharmaceutical Inc.
<MULTIPLIER>                1,000
<CURRENCY>                  US Dollars

<S>                             <C>
<PERIOD-TYPE>                   3-Mos
<FISCAL-YEAR-END>               DEC-31-2000
<PERIOD-START>                  APR-01-2000
<PERIOD-END>                    JUN-30-2000
<EXCHANGE-RATE>                 1
<CASH>                          10609
<SECURITIES>                    38803
<RECEIVABLES>                   1472
<ALLOWANCES>                    (70)
<INVENTORY>                     495
<CURRENT-ASSETS>                53532
<PP&E>                          26295
<DEPRECIATION>                  (5908)
<TOTAL-ASSETS>                 86090
<CURRENT-LIABILITIES>          2400
<BONDS>                        0
          0
                    0
<COMMON>                       35
<OTHER-SE>                     83587
<TOTAL-LIABILITY-AND-EQUITY>   86090
<SALES>                        713
<TOTAL-REVENUES>               3885
<CGS>                          164
<TOTAL-COSTS>                  164
<OTHER-EXPENSES>               10805
<LOSS-PROVISION>               0
<INTEREST-EXPENSE>             2
<INCOME-PRETAX>                (7086)
<INCOME-TAX>                   (7086)
<INCOME-CONTINUING>            (7086)
<DISCONTINUED>                 0
<EXTRAORDINARY>                0
<CHANGES>                      0
<NET-INCOME>                   (7086)
<EPS-BASIC>                    (0.20)
<EPS-DILUTED>                  (0.20)



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission